SCHOTT Pharma AG & Co KgaA
XETRA:1SXP

Watchlist Manager
SCHOTT Pharma AG & Co KgaA Logo
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Watchlist
Price: 28.1 EUR 1.59%
Market Cap: 4.2B EUR
Have any thoughts about
SCHOTT Pharma AG & Co KgaA?
Write Note

Income Statement

Earnings Waterfall
SCHOTT Pharma AG & Co KgaA

Revenue
948.6m EUR
Cost of Revenue
-624.4m EUR
Gross Profit
324.2m EUR
Operating Expenses
-154.8m EUR
Operating Income
169.4m EUR
Other Expenses
-19m EUR
Net Income
150.4m EUR

Income Statement
SCHOTT Pharma AG & Co KgaA

Rotate your device to view
Income Statement
Currency: EUR
Sep-2023 Dec-2023 Mar-2024 Jun-2024
Revenue
Revenue
899
N/A
1 131
+26%
1 365
+21%
949
-31%
Gross Profit
Cost of Revenue
(582)
(731)
(886)
(624)
Gross Profit
316
N/A
400
+26%
479
+20%
324
-32%
Operating Income
Operating Expenses
(145)
(172)
(226)
(155)
Selling, General & Administrative
(126)
(154)
(185)
(125)
Research & Development
(27)
(33)
(40)
(27)
Other Operating Expenses
7
15
(1)
(3)
Operating Income
171
N/A
228
+33%
254
+11%
169
-33%
Pre-Tax Income
Interest Income Expense
17
11
12
5
Non-Reccuring Items
7
8
8
2
Total Other Income
(9)
(5)
(5)
(3)
Pre-Tax Income
186
N/A
241
+30%
268
+11%
174
-35%
Net Income
Tax Provision
(34)
(45)
(46)
(23)
Income from Continuing Operations
152
196
222
151
Income to Minority Interest
(0)
(0)
(0)
(0)
Net Income (Common)
152
N/A
196
+29%
221
+13%
150
-32%
EPS (Diluted)
1.01
N/A
1.3
+29%
1.47
+13%
1
-32%

See Also

Discover More